Trust the experts at Eurofins with the preclinical assessment of your most promising candidates
The portfolio at Eurofins Pharma Discovery Services provides progressive evaluation of your study from tolerability and exposure through all levels of pharmacodynamics, including primary screening for activity and rank-ordering, lead identification, candidate selection, disease-specific efficacy and dose-dependent proof-of-concept in relevant translational studies.
We provides therapeutically focused disease models, incorporating biomarkers and outcome measures that enable greater prediction of clinical success. All in vivo studies are supported by a dedicated team of global Technical Directors specializing in specific therapeutic areas. The scientific experts at Eurofins, with their years of pharmaceutical drug development expertise, provide you ongoing project oversight, with prompt communication and a commitment to on-time reporting, enabling you to meet your strict drug-development timelines.
Our expert laboratory staff can formulate and dose test articles by virtually any route, including short- or long-term continuous infusion, and can monitor blood, brain, tissue and/or CSF exposure for PK/PD studies, as well as conduct biomarker analyses. Technical and Study Directors are readily available for consultations, allowing custom study designs to meet your budgetary needs.
Advantages of in vivo testing with Eurofins: